Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
63,390.91 +410.43 (+0.65%) CMC Crypto 200
1,317.24 +40.26 (+3.15%)
Lyell Immunopharma, Inc. (LYEL)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 2.4000 |
| Open | 2.4400 |
| Bid | 2.3300 x 100 |
| Ask | 2.4000 x 100 |
| Day's range | 2.3500 - 2.6600 |
| 52-week range | 1.3200 - 3.9700 |
| Volume | |
| Avg. volume | 905,590 |
| Market cap | 601.651M |
| Beta (5Y monthly) | -0.56 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Lyell Immunopharma, Inc.'s (NASDAQ:LYEL) market cap decline of US$89m may not have as much of an impact on institutional owners after a year of 1.4% returns
Key Insights Institutions' substantial holdings in Lyell Immunopharma implies that they have significant influence over...
- Zacks
Lyell Immunopharma (LYEL) Is Up 28.45% in One Week: What You Should Know
Does Lyell Immunopharma (LYEL) have what it takes to be a top stock pick for momentum investors? Let's find out.
- GuruFocus.com
Lyell Immunopharma Inc (LYEL) Reports 2023 Financial Results and Business Highlights
LYEL Advances Solid Tumor Cell Therapy Pipeline with Strong Cash Position into 2027
© 2024 Yahoo. All rights reserved.